IDYA - MCAP CO - IDEAYA Biosciences

The price history of IDEAYA Biosciences (IDYA) shares on the GURU.Markets platform, where the market capitalization stands at 3.54, reflects the company's business dynamics. Management is focused on developing highly specialized oncology drugs, actively securing investment through alliances with global pharmaceutical leaders. The brand's high authority in personalized medicine coexists with significant financial pressure due to massive R&D expenditures amid a lack of regular revenue.

IDEAYA Biosciences' leadership in synthetic lethality and precision oncology drives the dynamics of the company's market capitalization. This metric, representing the product of the current share price and the total number of outstanding securities, reflects the aggregate market value of the business and allows investors to assess the extent to which expectations for future R&D success are priced into the asset.